# A Study to Assess the Rel Bioavailability, Food Effect and Absolute Bioavailability on the Pharmacokinetics of AZD9833

> **NCT04546347** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 32 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **RADIATION:** [14C]AZD9833 Solution for Infusion, (NMT 22.8 kBq/5mL)
- **DRUG:** AZD9833 film-coated tablet A Dose 1
- **DRUG:** AZD9833 Oral Solution
- **DRUG:** AZD9833 film-coated tablet B Dose 1
- **DRUG:** AZD9833 film-coated tablet A Dose 2
- **DRUG:** AZD9833 film-coated tablet B Dose 2

## Key facts

- **NCT ID:** NCT04546347
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-17
- **Primary completion:** 2021-01-07
- **Final completion:** 2021-01-07
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2021-01-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04546347

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04546347, "A Study to Assess the Rel Bioavailability, Food Effect and Absolute Bioavailability on the Pharmacokinetics of AZD9833". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04546347. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*